Factors Affecting Cardiovascular Risk in Children, Adolescents, and Young Adults with Type 1 Diabetes. 2019

Ingrida Stankute, and Rimante Dobrovolskiene, and Evalda Danyte, and Dovile Razanskaite-Virbickiene, and Edita Jasinskiene, and Giedre Mockeviciene, and Dalia Marciulionyte, and Valerie M Schwitzgebel, and Rasa Verkauskiene
Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Cardiovascular risk and obesity are becoming major health issues among individuals with type 1 diabetes (T1D). The aim of this study was to evaluate cardiovascular risk factors and obesity in youth with T1D in Lithuania. Methods. 883 patients under 25 years of age with T1D for at least 6 months were investigated. Anthropometric parameters, blood pressure, and microvascular complications were evaluated, and the lipid profile and HbA1c were determined for all patients. Results. Study subjects' mean HbA1c was 8.5 ± 2%; 19.5% were overweight and 3.6% obese. Hypertension and dyslipidemia were diagnosed in 29.8% and 62.6% of participants, respectively. HbA1c concentration was directly related to levels of total cholesterol (r = 0.274, p < 0.001), LDL (r = 0.271, p < 0.001), and triglycerides (r = 0.407, p < 0.001) and inversely associated with levels of HDL (r = 0.117, p = 0.001). Prevalence of dyslipidemia increased with duration of diabetes (p < 0.05). Hypertension was more prevalent in overweight and obese compared to normal-weight patients (40.6 and 65.6 vs. 25.6%, respectively, p < 0.001). Frequency of microvascular complications was higher among patients with dyslipidemia (27.2 vs. 18.8%, p = 0.005) and among those with hypertension (25.9 vs. 23.2%, p < 0.001). Conclusion. The frequency of cardiovascular risk factors is high in youth with T1D and associated with diabetes duration, obesity, and metabolic control.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008097 Lithuania Country in eastern Europe, bordering the Baltic Sea, between Latvia and Russia, west of Belarus. The capital is Vilnius.
D008297 Male Males
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children

Related Publications

Ingrida Stankute, and Rimante Dobrovolskiene, and Evalda Danyte, and Dovile Razanskaite-Virbickiene, and Edita Jasinskiene, and Giedre Mockeviciene, and Dalia Marciulionyte, and Valerie M Schwitzgebel, and Rasa Verkauskiene
August 2008, European journal of pediatrics,
Ingrida Stankute, and Rimante Dobrovolskiene, and Evalda Danyte, and Dovile Razanskaite-Virbickiene, and Edita Jasinskiene, and Giedre Mockeviciene, and Dalia Marciulionyte, and Valerie M Schwitzgebel, and Rasa Verkauskiene
June 2015, Diabetes technology & therapeutics,
Ingrida Stankute, and Rimante Dobrovolskiene, and Evalda Danyte, and Dovile Razanskaite-Virbickiene, and Edita Jasinskiene, and Giedre Mockeviciene, and Dalia Marciulionyte, and Valerie M Schwitzgebel, and Rasa Verkauskiene
August 2012, European journal of pediatrics,
Ingrida Stankute, and Rimante Dobrovolskiene, and Evalda Danyte, and Dovile Razanskaite-Virbickiene, and Edita Jasinskiene, and Giedre Mockeviciene, and Dalia Marciulionyte, and Valerie M Schwitzgebel, and Rasa Verkauskiene
January 2017, Current diabetes reviews,
Ingrida Stankute, and Rimante Dobrovolskiene, and Evalda Danyte, and Dovile Razanskaite-Virbickiene, and Edita Jasinskiene, and Giedre Mockeviciene, and Dalia Marciulionyte, and Valerie M Schwitzgebel, and Rasa Verkauskiene
July 2012, Diabetes research and clinical practice,
Ingrida Stankute, and Rimante Dobrovolskiene, and Evalda Danyte, and Dovile Razanskaite-Virbickiene, and Edita Jasinskiene, and Giedre Mockeviciene, and Dalia Marciulionyte, and Valerie M Schwitzgebel, and Rasa Verkauskiene
January 2006, Przeglad lekarski,
Ingrida Stankute, and Rimante Dobrovolskiene, and Evalda Danyte, and Dovile Razanskaite-Virbickiene, and Edita Jasinskiene, and Giedre Mockeviciene, and Dalia Marciulionyte, and Valerie M Schwitzgebel, and Rasa Verkauskiene
July 2019, Journal of pediatric endocrinology & metabolism : JPEM,
Ingrida Stankute, and Rimante Dobrovolskiene, and Evalda Danyte, and Dovile Razanskaite-Virbickiene, and Edita Jasinskiene, and Giedre Mockeviciene, and Dalia Marciulionyte, and Valerie M Schwitzgebel, and Rasa Verkauskiene
December 2012, Current cardiovascular risk reports,
Ingrida Stankute, and Rimante Dobrovolskiene, and Evalda Danyte, and Dovile Razanskaite-Virbickiene, and Edita Jasinskiene, and Giedre Mockeviciene, and Dalia Marciulionyte, and Valerie M Schwitzgebel, and Rasa Verkauskiene
March 2024, Journal of clinical research in pediatric endocrinology,
Ingrida Stankute, and Rimante Dobrovolskiene, and Evalda Danyte, and Dovile Razanskaite-Virbickiene, and Edita Jasinskiene, and Giedre Mockeviciene, and Dalia Marciulionyte, and Valerie M Schwitzgebel, and Rasa Verkauskiene
June 2000, Journal of pediatric endocrinology & metabolism : JPEM,
Copied contents to your clipboard!